A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

MLA

Omar Mahmoud, et al. “A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer.” Advances in Radiation Oncology, vol. 4, Oct. 2019, pp. 631–40. EBSCOhost, https://doi.org/10.1016/j.adro.2019.04.003.

APA

Omar Mahmoud, Philippe Després, Maroie Barkati, Yaqun Wang, Frédéric Lacroix, William Foster, Guila Delouya, Daniel Taussky, Lara Hathout, Irina Vergalasova, Gerard Morton, André-Guy Martin, & Eric Vigneault. (2019). A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer. Advances in Radiation Oncology, 4, 631–640. https://doi.org/10.1016/j.adro.2019.04.003

Chicago

Omar Mahmoud, Philippe Després, Maroie Barkati, Yaqun Wang, Frédéric Lacroix, William Foster, Guila Delouya, et al. 2019. “A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer.” Advances in Radiation Oncology 4 (October): 631–40. doi:10.1016/j.adro.2019.04.003.